Immunogen (IMGN) call put ratio 22 calls to 1 put into AbbVie (ABBV) to acquire

Immunogen (NASDAQ: IMGN) December call option implied volatility is at 106, January is at 112; compared to its 52-week range of 50 to 217 into AbbVie (ABBV) to acquire ImmunoGen for $31.26 per share in cash. Call put ratio 22 calls to 1 put with focus on December 17 and January 21 calls into the bell.

You May Also Be Interested In

• Generac strikes $8B supply deal with Amazon for data center power
• iShares MSCI Brazil (EWZ) spreader active into Presidential elections, higher energy and commodity prices
• Moderna (MRNA) spreader of 1K contracts of September 25 weekly 157.50 and 165 calls as share price up 10.5%